Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.

Date Company Event Filing
SRX Global Inc. SRXH Material agreement signed Item 1.01 Form 8-K
Scribe Therapeutics, Inc. SCTX Results announced Item 2.02 Form 8-K
Senti Biosciences Holdings, Inc. SNTI Material agreement signed Item 1.01 Form 8-K
Senti Biosciences Holdings, Inc. SNTI Delisting notice Item 3.01 Form 8-K
Shuttle Pharmaceuticals Holdings, Inc. SHPH Other event Item 8.01 Form 8-K
Snowflake Inc. SNOW Results announced Item 2.02 Form 8-K
Solidion Technology Inc. STI Officer or director change Item 5.02 Form 8-K
Solidion Technology Inc. STI Regulation FD disclosure Item 7.01 Form 8-K
Southern Cross Acquisition II Corp. SCATU Other event Item 8.01 Form 8-K
Sprinklr, Inc. CXM Results announced Item 2.02 Form 8-K
Starling Oncology, Inc. STLN Officer or director change Item 5.02 Form 8-K
Sunbelt Rentals Holdings, Inc. SUNB Shareholder vote Item 5.07 Form 8-K
TELEPHONE & DATA SYSTEMS INC /DE/ TDS Other event Item 8.01 Form 8-K
TEN Holdings, Inc. XHLD Delisting notice Item 3.01 Form 8-K
TILLY'S, INC. TLYS Results announced Item 2.02 Form 8-K
TOMI Environmental Solutions, Inc. TOMZ Other event Item 8.01 Form 8-K
TREX CO INC TREX Results announced Item 2.02 Form 8-K
TREX CO INC TREX Results announced Item 2.02 Form 8-K
TScan Therapeutics, Inc. TCRX Restructuring or exit costs Item 2.05 Form 8-K
TScan Therapeutics, Inc. TCRX Delisting notice Item 3.01 Form 8-K
TScan Therapeutics, Inc. TCRX Officer or director change Item 5.02 Form 8-K
TScan Therapeutics, Inc. TCRX Regulation FD disclosure Item 7.01 Form 8-K
TScan Therapeutics, Inc. TCRX Other event Item 8.01 Form 8-K
TXNM ENERGY INC TXNM Regulation FD disclosure Item 7.01 Form 8-K
TXNM ENERGY INC TXNM Other event Item 8.01 Form 8-K
Triller Group Inc. ILLR Delisting notice Item 3.01 Form 8-K
U.S. GoldMining Inc. USGO Regulation FD disclosure Item 7.01 Form 8-K
Ultragenyx Pharmaceutical Inc. RARE Other event Item 8.01 Form 8-K
VAIL RESORTS INC MTN Officer or director change Item 5.02 Form 8-K
VOLITIONRX LTD VNRX Material agreement signed Item 1.01 Form 8-K
VOLITIONRX LTD VNRX Unregistered share sale Item 3.02 Form 8-K
VenHub Global, Inc. VHUB Material agreement signed Item 1.01 Form 8-K
VenHub Global, Inc. VHUB Delisting notice Item 3.01 Form 8-K
VenHub Global, Inc. VHUB Unregistered share sale Item 3.02 Form 8-K
Venture Global, Inc. VG Material agreement signed Item 1.01 Form 8-K
Venture Global, Inc. VG New debt or obligation Item 2.03 Form 8-K
Venture Global, Inc. VG Other event Item 8.01 Form 8-K
Vertiv Holdings Co VRT Material agreement signed Item 1.01 Form 8-K
Vertiv Holdings Co VRT Regulation FD disclosure Item 7.01 Form 8-K
Vertiv Holdings Co VRT Other event Item 8.01 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.